Michael Gaynon is an Ophthalmology physician affiliated with Stanford Medicine. OpenAlex indexes 42 publications with 466 citations (h-index 11); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions
Sponsor: Palo Alto Medical Foundation
- To Study the Effectiveness and Safety of Niacin and a Topical Steroid Eye Drop to Treat Retinal Vein Occlusions
Sponsor: Palo Alto Medical Foundation
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Mallinckrodt Hospital Products Inc.Program year20241 payment
- Genentech, Inc.Program year20231 payment
- Spark Therapeutics, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Long-Term Retinopathy of Prematurity Outcomes with Mandated Screening Interval and Grader Continuity at a High-Volume Quaternary Center
American Journal of Ophthalmology
2025 - Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial
Journal of Perinatology
2021 - Prethreshold retinopathy of prematurity: VEGF inhibition without VEGF inhibitors
Journal of Perinatology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Jeffrey Teuteberg, MD
Stanford Medicine
Charles Debattista, MD
Stanford Medicine
Jong Yoon, MD
Stanford Medicine
Kimberly Dequattro, MD, MM
Stanford Medicine
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”